For example, it is found that some genetic variants in the targets of sulphonylureas, the antidiabetic drugs that can stimulate insulin secretion by interacting with ATP‐sensitive potassium channels in the pancreas, are associated with a lower risk of AD.41 Here, INS is linked to Alzheimer disease.